drugset
Drugs / Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine
last change May 2017 re-read 3 minutes ago

Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine

Vaccine

Developed for
meningococcal meningitis
Investigated by
Air Force Military Medical University, China · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Guangdong Center for Disease Prevention and Control · Guizhou Center for Disease Control and Prevention · National Institutes for Food and Drug Control, China · Simoon Record Pharma Information Consulting Co., Ltd.

Trials 1

today NCT02919293 · Ph 1/2
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02919293 Aug 2016 → Mar 2017 meningococcal meningitis Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02919293 ↗
Modality Vaccine “Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free)” NCT02919293 ↗
Route Intramuscular “30μg /dose, Intramuscular” NCT02919293 ↗